Incyte (INCY) Shares Outstanding (Diluted) (2010 - 2026)

Incyte (INCY) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn 208.22 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 208.22 Mn
Mar 31, 2026 206.83 Mn
Dec 31, 2025 200.70 Mn
Sep 30, 2025 201.43 Mn
Jun 30, 2025 198.74 Mn
Mar 31, 2025 198.20 Mn
Dec 31, 2024 210.53 Mn
Sep 30, 2024 195.84 Mn
Jun 30, 2024 218.18 Mn
Mar 31, 2024 227.22 Mn
Dec 31, 2023 225.93 Mn
Sep 30, 2023 226.17 Mn
Jun 30, 2023 225.65 Mn
Mar 31, 2023 225.59 Mn
Dec 31, 2022 223.96 Mn
Sep 30, 2022 224.18 Mn
Jun 30, 2022 223.66 Mn
Mar 31, 2022 222.95 Mn
Dec 31, 2021 222.07 Mn
Sep 30, 2021 222.25 Mn